Hyderabad (Telangana) [India], November 3: Lee Pharma, a Hyderabad based Pharmaceutical Company, has received a Marketing Authorization for Bio-Cartilage Smoothwalk Tablets to market in United Arab Emirates region.
This will be a milestone in the history of the company. Bio-Cartilage Smoothwalk Tablets is the first product in the nutraceutical segment from India to get approved in UAE.
Bio-Cartilage Smoothwalk Tablets are already well accepted in India, being used in the prevention therapy of knee Surgery and giving excellent relief for the patients who are suffering with painful and Progressive Arthritis, says Company Director, Alla Leela Rani.
Further this product is under registration in all Middle East, East Asian Countries and scheduled to file the Dossier in US in 3rd Qtr. 2024 for marketing Authorization says Company Director.
Bio-Cartilage Smoothwalk Tablets contains collagen type II, natural egg shell membrane, Boswellia and curcumin with vitamin D3 which mainly acts on joint and connective tissue disorders to increase cartilage in joints. A Novel Composition of Bio Nutraceuticals with potent Phyto Nutrients to prevent joint and connective tissue disorders.
We have observed that administration of Bio-Cartilage Smoothwalk Tablets in arthritis patients for 2 to 3 tablets a day is getting fast relief within 3 weeks from the pains. This improves lubrication, mobility and flexibility in joints. Which may help to avoid surgeries.
Bio-Cartilage Smoothwalk Tablets are available on all online stores like Amazon, website : www.leehealthdomain.com and all the leading pharmacies in India.
(Disclaimer: The above press release comes to you under an arrangement with PNN and PTI takes no editorial responsibility for the same.). PTI PWR
PWR